LONDON, April 17- Drugmaker GlaxoSmithKline- hit by bribery claims in five countries- is to employ hundreds more doctors as members of staff as it seeks to build a new sales model designed to eliminate sharp marketing practices.» Read More
A first-hand look at American companies engaging in bribery overseas, with John Perkins, "Confessions of an Economic Hit Man" author, who discusses the widespread problem.
Jorge Castaneda, former Foreign Minister of Mexico and NYU professor, discusses the Wal-Mart bribery scandal and conducting business south of the border.
CNBC's Eamon Javers reports on Washington's views on the U.S. Foreign Corrupt Practices Act, amid Wal-Mart's Mexican bribery investigation, with Alexandra Wrage, TRACE International president.
Patrick McKeever, MKM Partners senior equity analyst, discusses the importance of the Mexican markets for Wal-Mart's growth and the impact the alleged scandal could have on the company's stock and executives.
CNBC's Michelle Caruso-Cabrera reports on the culture of doing business in Mexico, saying Wal-Mart is the largest private employer in Mexico and yet, barely any newspapers carried the story on the front page.
The Squawk on the Street team discusses the latest major headlines, including lower futures since concerns in Europe continue and how shares of Wal-Mart are faring since The New York Times reported the company is in the middle of an alleged bribery controversy.
The Squawk on the Street team report on the issues facing the Street ahead of Monday's open, and Jim Cramer weighs in on Wal-Mart's alleged bribery investigation in Mexico.
CNBC's Michelle Caruso-Cabrera and Scott Cohn provide the latest details on Wal-Mart's efforts to make a bribery case go away and the crackdown on foreign corruption. Also, a look inside Wal-Mart's culture, with CNBC's David Faber.
Jacob Frenkel, former SEC enforcement attorney, discusses the consequences Wal-Mart could face following allegations it tried to cover up a bribery investigation in Mexico.
CNBC's Courtney Reagan reports the latest details and fallout from an alleged bribery scandal in Mexico that hit Wal-Mart years ago.
A look at the U.S. markets ahead of the open, including an alleged bribery scandal involving Wal-Mart and its Mexican stores, and Pfizer selling its infant nutrition business to Nestles for $11.9B, with CNBC's Jackie DeAngelis.
Did Wal-Mart's Mexican division orchestrate a campaign of bribery to grab market dominance? Jeffrey Sonnenfeld, Yale School of Management weighs in on the investigation.
CNBC's Maria Bartiromo discusses investment opportunities in Russia, with Stephen Schwarzman, Blackstone chairman/CEO.
Dozens of foreign companies with London listings may be exempt from new anti-corruption laws, Ken Clarke has confirmed, a disclosure that will anger investors keen to preserve the integrity of London’s markets, the Financial Times reports.